ArticleActa pharmaceutica Sinica. B2021

Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR.

Xiaojia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.